Blood Diagnostics

Selected news for the healthcare topic - Blood Diagnostics, collected since 11/2017. Recent stories appear in Business Wire and ourcrowd.com. This healthcare topic shares news with T2 Biosystems, Genalyte, Kevin Lo and many others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics
Companies
Capital Firms
People

Selected Headines

Date Headline (link) Source Relevant Snippet
12/9/2020 Sight Diagnostics® Expands to the Gulf Region through a Distribution Partnership with Phoenix Capital Business Wire ... settings. As such, there is an increasing demand for modern POC diagnostics in the Middle East and Africa, with the market projected to reach $2.85 billion by 2024 .Sight OLO enables fast, accurate, convenient blood diagnostics by delivering CBC results in minutes right at the point-of-care . About the size of a toaster oven, OLO is small, compact, and light-weight, allowing for quick, simple set-up wherever it ...
12/2/2020 [Sight Diagnostics in MedCity News] MedCity Pivot Podcast: Sight Diagnostic's exec talks about using computer vision in blood diagnostics ourcrowd.com JoinSelect Page [Sight Diagnostics in MedCity News] MedCity Pivot Podcast: Sight Diagnostic’s exec talks about using computer vision in blood diagnosticsDec 2, 2020 News Center Share: In this episode of the MedCity Pivot podcast, Daniel Levner, co-founder and chairman of the scientific advisory board at Sight Diagnostics, explains how computer vision is changing blood diagnostics ...
11/30/2020 MedCity Pivot Podcast: Sight Diagnostic's exec talks about using computer vision in blood diagnostics MedCity News Due to the infamy of Theranos , even those not involved in the world of healthcare, know something about blood diagnostics and the effort to make it less burdensome.While the Theranos saga has burned investors, revealed a troubled entrepreneur and perhaps even created some hurdles for women entrepreneurs, other startups with similar aims haven’t given up their ambition to transform the world of complete blood count testing and other ...
11/2/2020 COVAXX and Maersk Enter Partnership to Supply COVID-19 Vaccines Globally logistics-manager.com ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials ...
10/28/2020 COVAXX, a U.S. company developing a multitope synthetic pept hellenicshippingnews.com ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials ...
10/28/2020 Maersk and COVAXX partner to supply global COVID-19 vaccines supplychaindigital.com ... The investigational vaccine has been manufactured to replicate natural biology and preclinical studies have outlined high immunogenicity and levels of neutralising titers against SARS-COV-2. The technology platform has been successful in commercialising blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in a number of clinical trials for other indications to date.The organisation is currently conducting Phase ...
10/26/2020 COVAXX and Maersk partner for COVID-19 vaccines maritimeprofessionals.net ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials of ...
10/26/2020 COVAXX and Maersk enter partnership to supply COVID-19 vaccines globally ajot.com ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials ...
9/20/2020 Tamanaha_Takashi shared "森友問題 自殺職員の妻が訴え「菅さん逃げないで」|テレ朝news" blogspot.com ... achieve Unicorn status Research from New York Data Analytics firm CB Insights revealed the Arab world has just one single Unicorn Read more at Twitter DrEddyClinic 🇩🇪 and 1 other shared dreddymd.com Dark field blood diagnostics Dark field blood diagnostics is a Method of Professor Dr. Guenther Enderlein (1872-1968), that primarily a biologist ... Read more at Twitter DrEddyClinic 🇩🇪 and 1 other shared dreddymd.com 10 Best Herbs for Boosting Female ...
9/11/2020 Sight Diagnostics Gets $71 Million in Series D Funding healthcareweekly.com Shopping for Healthcare In a confirmation of its standing and potential in the blood diagnostics industry and its new flagship blood analysis product, Sight Diagnostics the company that developed and manufactured the first FDA-approved finger stick Complete Blood Count analyzer has raised $71 million dollars in its series D round of funding. Sight Diagnostics has become a market leader by developing an exciting blood diagnostics device that cuts the ...
9/9/2020 COVAXX Synthetic Multitope Vaccine Selected for Human Trials in Brazil by Dasa, the Largest Diagnostic Company, and Mafra the Leading Private Vaccine Distributor PR Newswire ... arms. UB-612 is designed to mimic natural biology and preclinical studies have shown very high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date. "This donation is aligned with other efforts from ...
8/6/2020 PRESS RELEASE: Sight Diagnostics Raises $71M To Accelerate Global Expansion of itsFDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzer ourcrowd.com ... vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, President of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” Founded in 2011, Sight Diagnostics aims to transform blood testing through its flagship Sight ...
8/5/2020 Sight Diagnostics raises $71M Series D for its blood analyzer TechCrunch ... gather the data to detect anomalies that may indicate the severity of some of the aspects of the disease. “We just kind of scratched the surface of the ability of AI to help with blood diagnostics ,” said Pollak. “Specifically now, there’s so much value around COVID in decentralizing diagnostics and blood tests. Think keeping people — COVID-negative or -positive — outside of hospitals to reduce the busyness of hospitals and reduce ...
8/5/2020 Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach FierceBiotech ... vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, president of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” RELATED: Tabletop blood count developer Sight raises $27.8M in series C round The cartridge ...
8/5/2020 Blood Diagnostics Firm Sight Raises $71M For System That Produces Quick Results nocamels.com ... vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, President of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world ...
8/5/2020 Sight Diagnostics hauls in $71M Series D for point-of-care blood analysis MobiHealthNews ... roughly $28 billion by 2026 with a CAGR of 6.6%. It cited advancing tech and the rising awareness of point-of-care diagnostics as key drivers of that growth. Sight's approach of AI-based blood diagnostics runs parallel to that of 1Drop Diagnostics. This startup, which raised $4.25 million in late 2018 , measures biomarkers from a single drop of blood and delivers a response within roughly 15 minutes via its ...
8/5/2020 Finger-Prick Blood Analyzer Company Raises $71M mpo-mag.com ... vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, president of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” Founded in 2011, Sight Diagnostics aims to transform blood testing through its flagship Sight ...
8/5/2020 Sight Diagnostics hauls in $71M Series D for fingerprick blood analysis MobiHealthNews ... roughly $28 billion by 2026 with a CAGR of 6.6%. It cited advancing tech and the rising awareness of point-of-care diagnostics as key drivers of that growth. Sight's approach of AI-based blood diagnostics runs parallel to that of 1Drop Diagnostics. This startup, which raised $4.25 million in late 2018 , measures biomarkers from a single drop of blood and delivers a response within roughly 15 minutes via its ...
7/22/2020 Workpath Announces 105% Customer Count Growth from Q1 to Q2; Annual Revenue Growth of 50% PR Newswire RICHMOND, Va. , July 22, Workpath, the only on-demand dispatch and scheduling tech for mobile healthcare teams, is proud to announce a 105% increase in the company's customer count and a 50% increase in revenue from Q1 to Q2 2020. Platform usage has surged as well. Weekly appointment volume increased 165% since January when the first COVID-19 case was reported in the U.S. Since the launch of the platform ...
6/19/2020 Better Coronavirus Stock: Grifols or Novartis? | The Motley Fool fool.com ... company warrants investment? Image source: Getty Images. Grifols takes aim at the COVID-19 plasma therapeutics market Grifols has a lot to offer investors seeking steady growth. With a stable of products ranging from blood diagnostics to infusion-ready IV nutrition bags, the company competes in a handful of different markets, and its pipeline features seven different projects in clinical development. Considering its 11.8% year-over-year revenue growth, Grifols ...